Related content

Interpretation of Urine Drug Testing Results in Patients Using Transdermal Buprenorphine Preparations for the Treatment of Chronic Noncancer Pain

By  

PAIN MEDICINE, Vol. 16, Iss. 6, 2015-06 ,pp. : 1132-1136

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Use of High Dosages of Transdermal Buprenorphine for Pain Management in Palliative Cancer Patients: A Case Study

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-03 ,pp. : 169-173

Karger

Access to resources Recommend Favorite

Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland

By Przeklasa-Muszynska Anna   Dobrogowski Jan  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1109-1117

Informa Healthcare

Access to resources Recommend Favorite

Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control

By Pavelka Karel   Le Loet Xavier   Bjorneboe Olav   Herrero-Beaumont Gabriel   Richarz Ute  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 1967-1977

Informa Healthcare

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite